Every year, approximately 15 million people worldwide experience a stroke. While acute stroke care has made remarkable progress, the road to recovery often remains a long and challenging journey. Regaining arm and hand function is estimated to be a lifelong challenge for around 40% of stroke survivors. Frustration during rehabilitation is common, and new research now offers a concerning explanation.
A recent study has revealed a striking gap in current clinical practice: during the acute phase after stroke, patients receive, on average, only eight minutes of targeted upper-limb rehabilitation per day. For individuals striving to regain independence, this amounts to little more than a drop in the ocean. It raises an important question: Is recovery limited by biology—or simply by a profound underdosing of therapy?
The "Chronic" Myth: Why It Is Never Too Late to Start Again
For many years, rehabilitation medicine was guided by the belief that meaningful recovery could only occur during the so-called "golden window" of the first weeks and months after a stroke. Once patients entered the chronic stage—typically defined as more than six months after stroke—neurological recovery was often considered complete. Today, this view is increasingly recognized as outdated and unnecessarily limiting for patients.
Modern neuroscience has shown that the brain remains capable of reorganizing itself—even years after a stroke. It simply requires the right stimulus to reactivate neural networks. In fact, patients in the chronic stage can achieve functional improvements through high-intensity rehabilitation that are comparable to those observed during the acute phase. Earlier meta-analyses reported an average improvement of 2.2 points on the Action Research Arm Test (ARAT) during early rehabilitation, while intensive interventions in chronic stroke survivors achieved an average improvement of 2.69 points. The message is clear: the window for recovery does not simply close—we must learn to provide a sufficiently strong therapeutic stimulus.
The 200% Threshold: Why "A Little More" Is Not Enough
Perhaps the most striking finding of the recent meta-analysis by Patel et al. (2026) is the identification of an apparent therapeutic threshold. Contrary to common assumptions, modest increases in therapy time—such as 50% or even 100%—produce little measurable improvement in upper-limb function.
The real clinical breakthrough occurs only when therapy intensity increases by at least 200%, effectively tripling the amount of rehabilitation. Across the included studies, this substantial increase resulted in a mean improvement of 13.86 points on the Action Research Arm Test (ARAT)—well beyond the threshold generally considered meaningful for everyday function.
Where Is the Limit? The Search for a Ceiling Effect
In many areas of medicine, more treatment eventually reaches a point of diminishing returns. Researchers therefore continue to investigate whether a similar ceiling effect exists in neurorehabilitation—a point beyond which additional therapy no longer produces meaningful gains.
Current evidence, however, suggests otherwise. Studies evaluating intensive rehabilitation programmes, including so-called boot camps and highly specialized interventions such as the Queen Square Programme, demonstrate continued functional improvements even at extremely high therapy doses of 80 to 90 hours delivered over only a few weeks. Although recovery does not necessarily progress in a perfectly linear fashion—the brain does not learn like a computer—the overall trend is unmistakable: more therapeutic input produces greater functional gains. At present, patient outcomes appear to be constrained more by the structural limitations of healthcare systems than by the biological capacity of the human brain.
Quality Through Quantity: The Power of Repetition
It would be a mistake to assume that successful rehabilitation is simply a matter of spending more time in the therapy room. The critical factor is the combination of therapy duration and task-specific content. Positive outcomes were achieved only through repetitive, goal-directed practice that focused on meaningful functional activities.
Outcome measures such as the Fugl-Meyer Assessment (FMA) and the Wolf Motor Function Test (WMFT) consistently demonstrate that therapy dosage becomes the decisive factor when evidence-based interventions are delivered. Quantity is therefore not a substitute for quality—it is the prerequisite that allows quality to have its full effect. Only through large numbers of purposeful repetitions does the brain receive the stimulation required to strengthen new neural pathways and compensate for damaged ones.
A New Gold Standard for Stroke Rehabilitation?
The findings of this meta-analysis represent an important wake-up call for clinicians. They provide a concrete benchmark for clinical practice: to achieve truly meaningful improvements during the chronic stage after stroke, patients should ideally receive 40 to 75 hours of targeted upper-limb rehabilitation over a period of six to ten weeks.
Such an approach represents a fundamental shift away from short, intermittent therapy sessions toward concentrated periods of intensive rehabilitation. Larger clinical trials are still needed to confirm these therapeutic thresholds and ultimately establish them within future clinical guidelines.
[1] A validated assessment of upper-limb function consisting of 19 tasks evaluating grasp, grip, pinch, and gross arm movements. Scores range from 0 to 57, with higher scores indicating better functional performance.
[2] An interdisciplinary, evidence-based rehabilitation programme developed at the National Hospital for Neurology and Neurosurgery in London. It combines physiotherapy, occupational therapy, and patient education to restore functional movement and improve daily performance in individuals with neurological disorders.
References
- Patel, M., Serrada, I. & Hordacre, B. (2026). Does more rehabilitation lead to better upper limb outcomes after stroke? Asystematic review.Front. Rehabil. Sci. 7:1753677. doi: 10.3389/fresc.2026.1753677
This article is intended for the continuing professional education of hand therapists and rehabilitation professionals. It does not replace individualized clinical assessment or medical advice. All references were reviewed to the best of our knowledge (July 2026).
The IHHC Editorial Team is responsible for creating, reviewing, and continuously updating the content published by the International Hand Health Community (IHHC). Its mission is to present current knowledge from hand therapy, occupational therapy, physiotherapy, rehabilitation, and medicine in a way that is evidence-based, practical, and easy to understand.